Synapse Open Synapse
Biology

STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy

STAT News · · 1 min read

Medical mystery at the AHA conference: A Novartis drug lowered a risk marker for cardiovascular disease but did not lower chance of heart attack or stroke.

Latest from STAT News